We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

179 hedge funds and large institutions have $2.35B invested in Nektar Therapeutics in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 70 increasing their positions, 50 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

52% more capital invested

Capital invested by funds: $1.55B → $2.35B (+$799M)

40% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 50

8% more funds holding

Funds holding: 166 → 179 (+13)

7% more call options, than puts

Call options by funds: $5.89M | Put options by funds: $5.51M

Holders
179
Holders Change
+13
Holders Change %
+7.83%
% of All Funds
4.7%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.1%
New
35
Increased
70
Reduced
50
Closed
20
Calls
$5.89M
Puts
$5.51M
Net Calls
+$384K
Net Calls Change
+$263K

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$21.4M
2
CCM
Camber Capital Management
Massachusetts
+$17.1M
3
Deutsche Bank
Deutsche Bank
Germany
+$10.4M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$8.11M
5
RHJA
Rice Hall James & Associates
California
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$40.2M
2
State Street
State Street
Massachusetts
-$19.1M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$14M
4
BJCM
Blue Jay Capital Management
California
-$12.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OppenheimerFunds
New York
$438M -$5.44M -26,442 -2%
Primecap Management
2
Primecap Management
California
$333M +$554K +2,693 +0.2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$176M +$3.56M +17,301 +3%
BFA
4
BlackRock Fund Advisors
California
$166M +$957K +4,653 +0.7%
First Trust Advisors
5
First Trust Advisors
Illinois
$162M -$10.8M -52,371 -8%
Invesco
6
Invesco
Georgia
$73.7M +$2.45M +11,922 +4%
Federated Hermes
7
Federated Hermes
Pennsylvania
$65.4M +$4.05M +19,690 +8%
CCM
8
Camber Capital Management
Massachusetts
$59M +$17.1M +83,333 +56%
State Street
9
State Street
Massachusetts
$56.1M -$19.1M -92,683 -29%
BIT
10
BlackRock Institutional Trust
California
$55.5M +$1.67M +8,117 +4%
JHIU
11
Janus Henderson Investors US
Colorado
$39.9M +$996K +4,845 +3%
BA
12
BlackRock Advisors
Delaware
$39.5M +$618K +3,006 +2%
Norges Bank
13
Norges Bank
Norway
$36M – – –
GIM
14
Granahan Investment Management
Massachusetts
$35.1M -$3.26M -15,835 -10%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$31.5M +$1.19M +5,792 +5%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$28.8M – – –
AG
17
Artal Group
Luxembourg
$27M -$2.74M -13,333 -11%
BM
18
Bridger Management
New York
$26.4M +$21.4M +104,257 New
Northern Trust
19
Northern Trust
Illinois
$26.3M +$505K +2,458 +2%
PAM
20
Panagora Asset Management
Massachusetts
$22.8M +$778K +3,784 +4%
Principal Financial Group
21
Principal Financial Group
Iowa
$20.4M +$775K +3,767 +5%
Millennium Management
22
Millennium Management
New York
$18.5M -$40.2M -195,677 -73%
Deutsche Bank
23
Deutsche Bank
Germany
$17.7M +$10.4M +50,720 +261%
JP Morgan Chase
24
JP Morgan Chase
New York
$17.2M +$923K +4,490 +7%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$16.2M +$8.11M +39,450 +160%
1
2 3 4 5

NKTR Hedge Fund Activity: Q4 2015 in Review

179 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q4 2015, worth a combined $2.35B — up 52% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new NKTR positions and 20 closed out — a net gain of 15 holders — while 70 added to existing stakes and 50 trimmed.

The largest buyer was Bridger Management, opening a new position worth an estimated $21.4M. The largest seller was Millennium Management, cutting an estimated $40.2M.

  • 179 institutional investors held Nektar Therapeutics (NKTR) as of Q4 2015, up from 166 in Q3 2015.
  • Funds reported $2.35B of Nektar Therapeutics stock for Q4 2015, up 52% quarter-over-quarter.
  • 35 funds opened new Nektar Therapeutics positions in Q4 2015 and 20 closed out, a net change of +15 holders.
  • The largest Nektar Therapeutics buyer in Q4 2015 was Bridger Management, an estimated $21.4M added.
  • The largest Nektar Therapeutics seller in Q4 2015 was Millennium Management, an estimated $40.2M sold.

Based on aggregated 13F filings for Q4 2015.